|
LRRC37A4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.238200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.128100E-02 |
| Normal-vs-Stage2 |
4.197900E-02 |
| Normal-vs-Stage3 |
2.419200E-04 |
| Normal-vs-Stage4 |
5.991400E-04 |
| Stage1-vs-Stage2 |
5.194600E-01 |
| Stage1-vs-Stage3 |
1.241870E-02 |
| Stage1-vs-Stage4 |
1.759730E-02 |
| Stage2-vs-Stage3 |
3.032400E-01 |
| Stage2-vs-Stage4 |
3.048200E-01 |
| Stage3-vs-Stage4 |
8.980400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.436300E-03 |
| Normal-vs-AfricanAmerican |
6.178600E-01 |
| Normal-vs-Asian |
3.509000E-01 |
| Caucasian-vs-AfricanAmerican |
1.406750E-01 |
| Caucasian-vs-Asian |
1.039040E-01 |
| AfricanAmerican-vs-Asian |
8.057200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.168440E-04 |
| Normal-vs-Female |
3.958000E-02 |
| Male-vs-Female |
2.200400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.289220E-01 |
| Normal-vs-Age(41-60Yrs) |
1.383780E-02 |
| Normal-vs-Age(61-80Yrs) |
3.432400E-04 |
| Normal-vs-Age(81-100Yrs) |
5.362700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.005000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.336200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.985600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.506030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.195220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.118800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.440800E-03 |
| Classical-VS-Follicular |
4.215500E-02 |
| Classical-VS-Other |
1.404700E-04 |
| Classical-VS-Normal |
9.125700E-02 |
| Tall-VS-Follicular |
3.141600E-01 |
| Tall-VS-Other |
7.667900E-02 |
| Tall-VS-Normal |
1.974440E-04 |
| Follicular-VS-Other |
2.656700E-03 |
| Follicular-VS-Normal |
2.579800E-03 |
| Other-VS-Normal |
1.65990000000615E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.681600E-02 |
| Normal-vs-N1 |
1.048060E-02 |
| N0-vs-N1 |
5.837000E-01 |
|
|
